Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Frontiers in Oncology

Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response

  • Jacobo Rogado1
  • Elisabet González del Portillo2
  • Diego Casado Elía3
  • Jaime Rubio-Perez4
4 affiliations
  1. 1Department of Medical Oncology, Hospital Universitario de La Princesa
  2. 2Department of Radiation Oncology, Hospital Universitario Rey Juan Carlos
  3. 3Department of Medical Oncology, Hospital General de Villalba
  4. 4Department of Medicine, Memorial Sloan Kettering Cancer Center
Open at sourcePDFDOICite

Related

  1. Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches
    Ünal Metin Tokat, Nalan Akgul Babacan, Mutlu Demiray
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.
    Ruijie An, Ningning He, Wendong Gu
    Cancer sciencePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. Multimodal biomarkers for early detection and immunotherapy assessment in hepatocellular carcinoma: integrating liquid biopsy, AI-based imaging and tumor immune profiling.
    Yuli Zhao, Xiaolei Chen, Hanyu Zhao
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Editorial: Chemoresistance and immunotherapy in solid tumors
    Junchao Xu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
    Nethaji Muniraj, Mohanraj Sadasivam, Chellappagounder Thangavel
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{rogado2026editorial,
  title = {{Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response}},
  author = {Jacobo Rogado and Elisabet González del Portillo and Diego Casado Elía and Jaime Rubio-Perez},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = oct,
  doi = {10.3389/fonc.2026.2002791},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.2002791/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
AU  - Jacobo Rogado
AU  - Elisabet González del Portillo
AU  - Diego Casado Elía
AU  - Jaime Rubio-Perez
PY  - 2026
DA  - 2026/10/05
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.2002791
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.2002791/full
SN  - 2234-943X
ER  -